| ǥ :
|
ȣ - 480508 41 |
| Multi-vessel disease with drug-eluting stent implantation |
| Division of Cardiology, Internal Medicine, Dongsan Medical Center, Keimyung University |
| Yun-Kyeong Cho, Seung-Ho Hur, Min-Jung Kim, Chang-Wook Park, Sang-Hoon Lee, Chang-Wook Nam, Young-Soo Lee, Seong-Wook Han, Kee-Sik Kim, Yoon-Nyun Kim, Kwon-Bae Kim |
Background: Drug-eluting stent (DES) implantation showed a lower angiographic restenosis and revascularization. But, the safety and clinical outcomes of DES in patients with multi-vessel disease is unknown. Objectives: We evaluated the angiographic and clinical parameters in patients with multi-vessel DES implantation. Methods: 93 DES were implanted in 39 patients between February 2003 and January 2004. Major adverse cardiac events were analyzed. Results: Mean follow-up duration was 8 months. 6 month follow-up angiogram was done in 56% (22 patients). See as a following table. Conclusions: DES implantation showed favorable acute and mid-term outcomes. Therefore this strategy is effective for the treatment of multi-vessel disease.
|
|
|
DES
(n = 39 patients) |
|
Age,
yrs
Men,
%
Diabetes
mellitus, %
SA / UA /
AMI, %
Two- / Three-vessel disease,
%
LAD / LCX / RCA,
%
Lesion type : A / B1 / B2 / C,
%
Number of DES per
patient
Lesion length/Stent length,
mm
Pre RVD/ Post MLD,
mm
Post-procedural
MI
Acute or Subacute
thrombosis
QCA restenosis
TVR/Nonfatal
MI/Death |
61.8
± 10.4
27
(69.2%)
11
(28.2%)
13/9/17 (33/23/44%)
19/20 (49/51%)
33/38/22 (35/41/24%)
4/30/8/51 (4/32/9/55%)
2.8
± 1.1
22.6
± 11.3/27.3 ± 11.6
3.0
± 0.4/2.9 ± 0.3
10
(25.6%)
0
(0%)
2
(3.7%)
2/0/0 (3.7/0/0%) |
|
RVD : reference vessel
diameter, MLD : minimal lumen diameter,
QCA : quantitative coronary
angiogram, TVR : target vessel revascularization |
|
|
|
